189 related articles for article (PubMed ID: 8471899)
21. [Clinical studies of norfloxacin in urinary tract infections].
Matsuura T; Kurita T
Hinyokika Kiyo; 1985 Nov; 31(11):2085-9. PubMed ID: 4091145
[TBL] [Abstract][Full Text] [Related]
22. Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tract.
Karp JE; Merz WG; Hendricksen C; Laughon B; Redden T; Bamberger BJ; Bartlett JG; Saral R; Burke PJ
Scand J Infect Dis Suppl; 1986; 48():66-78. PubMed ID: 3535055
[TBL] [Abstract][Full Text] [Related]
23. Five-day therapy with cephradine capsules, 500 mg BID, for the treatment of acute, uncomplicated urinary tract infections.
Brosof AB
Clin Ther; 1980; 3(4):285-91. PubMed ID: 7023676
[TBL] [Abstract][Full Text] [Related]
24. Double-blind comparison of 3-day versus 7-day treatment with norfloxacin in symptomatic urinary tract infections. The Inter-Nordic Urinary Tract Infection Study Group.
Scand J Infect Dis; 1988; 20(6):619-24. PubMed ID: 2906171
[TBL] [Abstract][Full Text] [Related]
25. Comparative trial of norfloxacin and macrocrystalline nitrofurantoin (Macrodantin) in the prophylaxis of recurrent urinary tract infection in women.
Brumfitt W; Hamilton-Miller JM; Smith GW; al-Wali W
Q J Med; 1991 Oct; 81(294):811-20. PubMed ID: 1801054
[TBL] [Abstract][Full Text] [Related]
26. Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women.
Nicolle LE; Madsen KS; Debeeck GO; Blochlinger E; Borrild N; Bru JP; Mckinnon C; O'Doherty B; Spiegel W; Van Balen FA; Menday P
Scand J Infect Dis; 2002; 34(7):487-92. PubMed ID: 12195873
[TBL] [Abstract][Full Text] [Related]
27. [Norfloxacine efficacy in acute cystitis in the region with 10% resistance of E. coli to fluoroquinolones: a comparative randomized study].
Rafal'skiĭ VV; Malev IV; Derevitskiĭ AV; Kozlov SN; Galkin VV
Urologiia; 2009; (3):18-21. PubMed ID: 19670810
[TBL] [Abstract][Full Text] [Related]
28. [Clinical study of NFLX (norfloxacin) in complicated urinary tract infections].
Murase T; Mitsuya H; Fukatsu H; Yoshida K; Natsume H; Obata K; Ohshima S; Asaka H; Kobayashi M; Okamura K
Hinyokika Kiyo; 1986 Aug; 32(8):1167-75. PubMed ID: 3788743
[TBL] [Abstract][Full Text] [Related]
29. Treatment of recurrent urinary tract infection with norfloxacin versus trimethoprim-sulfamethoxazole.
Seidmon EJ; Krisch EB; Truant AL; Amy BG; Childs SJ; Hurst AT; McCabe RE
Urology; 1990 Feb; 35(2):187-93. PubMed ID: 2407023
[TBL] [Abstract][Full Text] [Related]
30. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study.
Arredondo-García JL; Figueroa-Damián R; Rosas A; Jáuregui A; Corral M; Costa A; Merlos RM; Ríos-Fabra A; Amábile-Cuevas CF; Hernández-Oliva GM; Olguín J; Cardeñosa-Guerra O;
J Antimicrob Chemother; 2004 Oct; 54(4):840-3. PubMed ID: 15347634
[TBL] [Abstract][Full Text] [Related]
31. Norfloxacin treatment in complicated urinary tract infection.
Boerema JB; van Saene HK
Scand J Infect Dis Suppl; 1986; 48():20-6. PubMed ID: 3465030
[TBL] [Abstract][Full Text] [Related]
32. A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury.
Dow G; Rao P; Harding G; Brunka J; Kennedy J; Alfa M; Nicolle LE
Clin Infect Dis; 2004 Sep; 39(5):658-64. PubMed ID: 15356779
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of self-start therapy in women with recurrent urinary tract infections.
Schaeffer AJ; Stuppy BA
J Urol; 1999 Jan; 161(1):207-11. PubMed ID: 10037399
[TBL] [Abstract][Full Text] [Related]
34. Treatment of urinary infections: clinical perspectives.
Fontana G; Laudi M; Carlone NA; Savoia D
Chemioterapia; 1987 Feb; 6(1):45-9. PubMed ID: 3549009
[TBL] [Abstract][Full Text] [Related]
35. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
Wells WG; Woods GL; Jiang Q; Gesser RM
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
[TBL] [Abstract][Full Text] [Related]
36. [Clinical evaluation of norfloxacin preparation in treatment of bacterial infections of the urinary tract in patients with various kidney diseases].
Mazanowska O; Boratyńska M; Mróz E; Starek J
Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):154-7. PubMed ID: 8090671
[TBL] [Abstract][Full Text] [Related]
37. Double-blind, randomized comparison of 24 weeks of norfloxacin and 12 weeks of norfloxacin followed by 12 weeks of placebo in the therapy of complicated urinary tract infection.
Sheehan GJ; Harding GK; Haase DA; Thomson MJ; Urias B; Kennedy JK; Hoban DJ; Ronald AR
Antimicrob Agents Chemother; 1988 Aug; 32(8):1292-3. PubMed ID: 3056259
[TBL] [Abstract][Full Text] [Related]
38. Fosfomycin trometamol in a single dose versus norfloxacin for seven days in the treatment of uncomplicated urinary infections in general practice.
Boerema JB; Willems FT
Infection; 1990; 18 Suppl 2():S80-8. PubMed ID: 2286467
[TBL] [Abstract][Full Text] [Related]
39. The use of norfloxacin in a university hospital.
Alaniz C; Stumpf JL; Townsend KA
Hosp Pharm; 1991 Aug; 26(8):707-10, 719. PubMed ID: 10112581
[TBL] [Abstract][Full Text] [Related]
40. World-wide clinical experience with norfloxacin: efficacy and safety.
Wang C; Sabbaj J; Corrado M; Hoagland V
Scand J Infect Dis Suppl; 1986; 48():81-9. PubMed ID: 3535057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
